凝血因子Ⅸ(F9)重组蛋白

Recombinant Coagulation Factor IX (F9)

HEMB; FIX; GLA Domain; PTC; Anti Hemophilic Factor B; Christmas Factor; Plasma Thromboplastic Component; Christmas Disease; Hemophilia B

  • 凝血因子Ⅸ(F9)重组蛋白 产品包装(模拟)
  • 凝血因子Ⅸ(F9)重组蛋白 产品包装(模拟)
  • RPA840Rb03.jpg Figure. SDS-PAGE
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Oryctolagus cuniculus (Rabbit,兔) 应用(仅供研究使用,不用于临床诊断!)
RPA840Rb02 凝血因子Ⅸ(F9)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA840Rb03 凝血因子Ⅸ(F9)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA840Rb01 凝血因子Ⅸ(F9)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA840Rb51 凝血因子Ⅸ(F9)多克隆抗体 WB; IHC; ICC; IP.
LAA840Rb71 凝血因子Ⅸ(F9)多克隆抗体(生物素标记) WB; IHC; ICC.
MAA840Rb21 凝血因子Ⅸ(F9)单克隆抗体 WB
MAA840Rb22 凝血因子Ⅸ(F9)单克隆抗体 WB; IHC; ICC; IP.

参考文献

杂志 参考文献
Cardiovascular Research Loss of accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity [Pubmed:29444200]
留言咨询